Real	O
-	O
world	O
impact	O
of	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
overall	O
survival	O
in	O
resectable	O
breast	O
cancer	I:C0006142
.	O

Real	O
-	O
world	O
impact	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
overall	O
survival	O
in	O
resectable	O
breast	B:C0006142
cancer	I:C0006142
.	O

The	O
real	O
-	O
world	O
occurrence	O
rate	O
of	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
(	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
)	O
and	O
its	O
impact	O
on	O
patients	O
with	O
breast	O
cancer	I:C0006142
are	O
poorly	O
recognized	O
.	O

The	O
real	O
-	O
world	O
occurrence	O
rate	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
(	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
)	O
and	O
its	O
impact	O
on	O
patients	O
with	O
breast	O
cancer	I:C0006142
are	O
poorly	O
recognized	O
.	O

The	O
real	O
-	O
world	O
occurrence	O
rate	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
(	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
)	O
and	O
its	O
impact	O
on	O
patients	O
with	O
breast	B:C0006142
cancer	I:C0006142
are	O
poorly	O
recognized	O
.	O

Women	B:C0043210
with	O
resectable	O
breast	O
cancer	I:C0006142
from	O
1990	O
to	O
2007	O
in	O
the	O
Surveillance	O
,	I:C0242638
Epidemiology	I:C0242638
,	I:C0242638
and	I:C0242638
End	I:C0242638
Results	I:C0242638
database	I:C0242638
(	O
n	O
=	O
199,963	O
)	O
were	O
analyzed	O
.	O

Women	O
with	O
resectable	O
breast	B:C0006142
cancer	I:C0006142
from	O
1990	O
to	O
2007	O
in	O
the	O
Surveillance	O
,	I:C0242638
Epidemiology	I:C0242638
,	I:C0242638
and	I:C0242638
End	I:C0242638
Results	I:C0242638
database	I:C0242638
(	O
n	O
=	O
199,963	O
)	O
were	O
analyzed	O
.	O

Women	O
with	O
resectable	O
breast	O
cancer	I:C0006142
from	O
1990	O
to	O
2007	O
in	O
the	O
Surveillance	B:C0242638
,	I:C0242638
Epidemiology	I:C0242638
,	I:C0242638
and	I:C0242638
End	I:C0242638
Results	I:C0242638
database	I:C0242638
(	O
n	O
=	O
199,963	O
)	O
were	O
analyzed	O
.	O

Women	O
with	O
resectable	O
breast	O
cancer	I:C0006142
from	O
1990	O
to	O
2007	O
in	O
the	O
Surveillance	O
,	I:C0242638
Epidemiology	I:C0242638
,	I:C0242638
and	I:C0242638
End	I:C0242638
Results	I:C0242638
database	I:C0242638
(	O
n	O
=	O
199,963	O
)	O
were	O
analyzed	B:C0936012
.	O

The	O
outcome	O
events	O
of	O
breast	B:C0006142
cancer	I:C0006142
were	O
classified	O
as	O
breast	O
cancer	O
-	O
specific	O
death	O
(	O
BCSD	O
)	O
,	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
,	O
or	O
survival	O
.	O

The	O
outcome	O
events	O
of	O
breast	O
cancer	I:C0006142
were	O
classified	O
as	O
breast	O
cancer	O
-	O
specific	O
death	O
(	O
BCSD	O
)	O
,	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
,	O
or	O
survival	O
.	O

Binary	B:C0206031
logistics	I:C0206031
was	O
used	O
to	O
estimate	O
the	O
occurrence	O
rates	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
and	O
BCSD	O
with	O
different	O
clinicopathological	O
factors	O
.	O

Binary	O
logistics	I:C0206031
was	O
used	O
to	O
estimate	O
the	O
occurrence	O
rates	O
of	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
and	O
BCSD	O
with	O
different	O
clinicopathological	O
factors	O
.	O

The	O
Gray	B:C0282574
method	I:C0282574
was	O
used	O
to	O
measure	O
the	O
cumulative	O
incidence	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
and	O
BCSD	O
.	O

The	O
Gray	O
method	I:C0282574
was	O
used	O
to	O
measure	O
the	O
cumulative	O
incidence	O
of	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
and	O
BCSD	O
.	O

The	O
ratio	O
of	O
non-BCSDs	B:C1408354
to	O
all	O
causes	O
of	I:C0007465
death	I:C0007465
and	O
stacked	O
cumulative	O
incidence	O
function	O
plots	I:C0681493
were	O
used	O
to	O
present	O
the	O
impact	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
overall	O
survival	O
(	O
OS	O
)	O
.	O

The	O
ratio	O
of	O
non-BCSDs	O
to	O
all	O
causes	B:C0007465
of	I:C0007465
death	I:C0007465
and	O
stacked	O
cumulative	O
incidence	O
function	O
plots	I:C0681493
were	O
used	O
to	O
present	O
the	O
impact	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
overall	O
survival	O
(	O
OS	O
)	O
.	O

The	O
ratio	O
of	O
non-BCSDs	O
to	O
all	O
causes	O
of	I:C0007465
death	I:C0007465
and	O
stacked	B:C3272897
cumulative	O
incidence	O
function	O
plots	I:C0681493
were	O
used	O
to	O
present	O
the	O
impact	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
overall	O
survival	O
(	O
OS	O
)	O
.	O

The	O
ratio	O
of	O
non-BCSDs	O
to	O
all	O
causes	O
of	I:C0007465
death	I:C0007465
and	O
stacked	O
cumulative	O
incidence	O
function	B:C0681493
plots	I:C0681493
were	O
used	O
to	O
present	O
the	O
impact	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
overall	O
survival	O
(	O
OS	O
)	O
.	O

The	O
ratio	O
of	O
non-BCSDs	O
to	O
all	O
causes	O
of	I:C0007465
death	I:C0007465
and	O
stacked	O
cumulative	O
incidence	O
function	O
plots	I:C0681493
were	O
used	O
to	O
present	O
the	O
impact	O
of	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
overall	O
survival	O
(	O
OS	O
)	O
.	O

Models	B:C0010235
of	I:C0010235
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
and	O
competing	O
risk	I:C0034980
regression	I:C0034980
were	O
compared	O
to	O
highlight	O
the	O
suitable	O
model	I:C3161035
.	O

Models	O
of	I:C0010235
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
and	O
competing	B:C0034980
risk	I:C0034980
regression	I:C0034980
were	O
compared	O
to	O
highlight	O
the	O
suitable	O
model	I:C3161035
.	O

Models	O
of	I:C0010235
Cox	I:C0010235
proportional	I:C0010235
hazards	I:C0010235
regression	I:C0010235
and	O
competing	O
risk	I:C0034980
regression	I:C0034980
were	O
compared	O
to	O
highlight	O
the	O
suitable	B:C3161035
model	I:C3161035
.	O

There	O
were	O
12,879	O
non-BCSDs	B:C1408354
(	O
6.44	O
%	O
)	O
and	O
28,784	O
BCSDs	O
(	O
14.39	O
%	O
)	O
.	O

The	O
oldest	O
age	O
group	O
(	O
>	O
62	O
years	O
)	O
,	O
black	B:C0005680
race	I:C0005680
,	O
and	O
a	O
single	O
or	O
divorced	O
marital	O
status	O
were	O
associated	O
with	O
more	O
non-BCSDs	O
.	O

The	O
oldest	O
age	O
group	O
(	O
>	O
62	O
years	O
)	O
,	O
black	O
race	I:C0005680
,	O
and	O
a	O
single	O
or	O
divorced	O
marital	O
status	O
were	O
associated	O
with	O
more	O
non-BCSDs	B:C1408354
.	O

With	O
adjustments	O
for	O
age	O
,	O
a	O
hormone	B:C1562029
receptor	I:C1562029
-	I:C1562029
positive	I:C1562029
(	I:C1562029
HoR	I:C1562029
+	I:C1562029
)	I:C1562029
status	I:C1562029
was	O
no	O
longer	O
related	O
to	O
increased	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
s.	O

With	O
adjustments	O
for	O
age	O
,	O
a	O
hormone	O
receptor	I:C1562029
-	I:C1562029
positive	I:C1562029
(	I:C1562029
HoR	I:C1562029
+	I:C1562029
)	I:C1562029
status	I:C1562029
was	O
no	O
longer	O
related	O
to	O
increased	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
s.	O

In	O
patients	O
with	O
grade	B:C0012634
1	I:C0012634
,	I:C0012634
stage	I:C0012634
I	I:C0012634
disease	I:C0012634
and	O
an	O
HoR+	O
status	I:C1562029
as	O
well	O
as	O
the	O
oldest	O
subgroup	O
,	O
a	O
great	O
dilution	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
all	O
causes	O
of	I:C0007465
death	I:C0007465
could	O
be	O
observed	O
,	O
and	O
this	O
led	O
to	O
incorrect	O
interpretations	O
.	O

In	O
patients	O
with	O
grade	O
1	I:C0012634
,	I:C0012634
stage	I:C0012634
I	I:C0012634
disease	I:C0012634
and	O
an	O
HoR+	B:C1562029
status	I:C1562029
as	O
well	O
as	O
the	O
oldest	O
subgroup	O
,	O
a	O
great	O
dilution	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
all	O
causes	O
of	I:C0007465
death	I:C0007465
could	O
be	O
observed	O
,	O
and	O
this	O
led	O
to	O
incorrect	O
interpretations	O
.	O

In	O
patients	O
with	O
grade	O
1	I:C0012634
,	I:C0012634
stage	I:C0012634
I	I:C0012634
disease	I:C0012634
and	O
an	O
HoR+	O
status	I:C1562029
as	O
well	O
as	O
the	O
oldest	O
subgroup	O
,	O
a	O
great	O
dilution	O
of	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
all	O
causes	O
of	I:C0007465
death	I:C0007465
could	O
be	O
observed	O
,	O
and	O
this	O
led	O
to	O
incorrect	O
interpretations	O
.	O

In	O
patients	O
with	O
grade	O
1	I:C0012634
,	I:C0012634
stage	I:C0012634
I	I:C0012634
disease	I:C0012634
and	O
an	O
HoR+	O
status	I:C1562029
as	O
well	O
as	O
the	O
oldest	O
subgroup	O
,	O
a	O
great	O
dilution	O
of	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
on	O
all	O
causes	B:C0007465
of	I:C0007465
death	I:C0007465
could	O
be	O
observed	O
,	O
and	O
this	O
led	O
to	O
incorrect	O
interpretations	O
.	O

The	O
inaccuracy	O
,	O
caused	O
by	O
the	O
commonly	O
used	O
Cox	B:C0010235
proportional	I:C0010235
hazards	I:C0010235
model	I:C0010235
,	O
could	O
be	O
corrected	O
by	O
a	O
competing	O
risk	I:C0034980
model	I:C0034980
.	O

The	O
inaccuracy	O
,	O
caused	O
by	O
the	O
commonly	O
used	O
Cox	O
proportional	I:C0010235
hazards	I:C0010235
model	I:C0010235
,	O
could	O
be	O
corrected	O
by	O
a	O
competing	B:C0034980
risk	I:C0034980
model	I:C0034980
.	O

OS	O
was	O
largely	O
impaired	O
by	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
during	O
early	O
breast	O
cancer	I:C0006142
.	O

OS	O
was	O
largely	O
impaired	O
by	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
during	O
early	O
breast	B:C0006142
cancer	I:C0006142
.	O

For	O
some	O
future	O
clinical	B:C0008976
trial	I:C0008976
planning	O
,	O
especially	O
for	O
the	O
oldest	O
patients	O
and	O
those	O
with	O
hormone	O
receptor	I:C1562029
-	I:C1562029
positive	I:C1562029
breast	O
cancer	I:C0006142
,	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
should	O
be	O
considered	O
a	O
competing	O
risk	O
event	O
.	O

For	O
some	O
future	O
clinical	O
trial	I:C0008976
planning	O
,	O
especially	O
for	O
the	O
oldest	O
patients	O
and	O
those	O
with	O
hormone	B:C1562029
receptor	I:C1562029
-	I:C1562029
positive	I:C1562029
breast	O
cancer	I:C0006142
,	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
should	O
be	O
considered	O
a	O
competing	O
risk	O
event	O
.	O

For	O
some	O
future	O
clinical	O
trial	I:C0008976
planning	O
,	O
especially	O
for	O
the	O
oldest	O
patients	O
and	O
those	O
with	O
hormone	O
receptor	I:C1562029
-	I:C1562029
positive	I:C1562029
breast	B:C0006142
cancer	I:C0006142
,	O
non-breast	O
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
should	O
be	O
considered	O
a	O
competing	O
risk	O
event	O
.	O

For	O
some	O
future	O
clinical	O
trial	I:C0008976
planning	O
,	O
especially	O
for	O
the	O
oldest	O
patients	O
and	O
those	O
with	O
hormone	O
receptor	I:C1562029
-	I:C1562029
positive	I:C1562029
breast	O
cancer	I:C0006142
,	O
non-breast	B:C1408354
cancer	I:C1408354
-	I:C1408354
specific	I:C1408354
death	I:C1408354
should	O
be	O
considered	O
a	O
competing	O
risk	O
event	O
.	O

Â©	O
2017	O
American	B:C0002455
Cancer	I:C0002455
Society	I:C0002455
.	O

